Although the strength of association between anti-TNFs and the risk of infection remains a topic of debate [2–5], the evidence published so far underscores the need for clinicians to carefully balance the clinical benefits and potential harms of initiating anti-TNF therapy in individual patients. Here, TNF is linked to infection.